Sell2Wales.gov.wales uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies.

Accept cookies Cookie Settings

View Notice

The buyer is not using this website to administer the notice. To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Add notice to my Sell2Wales Interest List

Notice Details

Title: Purchase of Trinity MR/US Fusion Prostate Biopsy System
Published by: The Royal Marsden NHS Foundation Trust
Publication Date: 08/09/2020
Deadline Date:
Deadline Time:
Notice Type: VEAT
Has Documents: No
Has ESPD: No
Abstract:

The Royal Marsden Hospital NHS Foundation Trust needs to purchase Trinity MR/US fusion prostate biopsy system. This machine is central to delivering the RAPID programme. The Trust currently undertakes TRUS biopsies in the outpatient setting. TRUS biopsies are associated with a high level of sepsis (as the bx is taken via the rectum and not the perineum) therefore the Trust has to move to transperineal biospies to prevent this.

This system is only available from Koelis

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

The Royal Marsden NHS Foundation Trust

Unit G3, Harbour Yard, Chelsea Harbour

London

SW10 0XD

UK

Contact person: tenders@chelwest.nhs.uk

E-mail: tenders@chelwest.nhs.uk

NUTS: UKI

Internet address(es)

Main address: www.royalmarsden.nhs.uk

Address of the buyer profile: www.royalmarsden.nhs.uk

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Purchase of Trinity MR/US Fusion Prostate Biopsy System

Reference number: DN496124

II.1.2) Main CPV code

33100000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

The Royal Marsden Hospital NHS Foundation Trust needs to purchase Trinity MR/US fusion prostate biopsy system. This machine is central to delivering the RAPID programme. The Trust currently undertakes TRUS biopsies in the outpatient setting. TRUS biopsies are associated with a high level of sepsis (as the bx is taken via the rectum and not the perineum) therefore the Trust has to move to transperineal biospies to prevent this.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 170 000.00 GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKI

II.2.4) Description of the procurement

The Royal Marsden Hospital NHS Foundation Trust needs to purchase Trinity MR/US fusion prostate biopsy system. This machine is central to delivering the RAPID programme. The Trust currently undertakes TRUS biopsies in the outpatient setting. TRUS biopsies are associated with a high level of sepsis (as the bx is taken via the rectum and not the perineum) therefore the Trust has to move to transperineal biospies to prevent this.

This system is only available from Koelis

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the Official Journal of the European Union

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

The Trust intend to award Koelis for this purchase as there is no alternative machine on the market.

Koelis machine has several features which are required by the Trust:

1) Organ based tracking — tracks the shifting prostate and automatically compensates for these movements using solely the images and without any additional sensors therefore maximising the accuracy of the procedure and reducing the number of core biopsies needed to be undertaken by 1/3rd.

2) Free-hand biopsy capability — low cost disposable guides are available to facilitate this process.

3) Elastic fusion — the MRI scans are superimposed then automatically adjusted to better correspond to the contours of the ultrasound images in real time.

4) Koelis system facilitates biopsy in left lateral position (patient is lying on their side) as opposed to lithotomy position. The system can operates in such position even for the transperineal approach under local anesthesia. This makes the procedure more comfortable tolerable and the patient moves less. There is also pressure point protection (minimising chance of neuropraxia), which increases the speed of biopsy meaning more can be done during a session this significantly increases efficiency.

5) Highly portable system which doesn’t require recalibrating when moved. This means a single integrated device which can be moved between hospital sites to maximise use of the equipment.

6) Koelis technology allows to perform virtual biopsy which provides to the clinician the ability to plan and check with high precision the needle positioning before actually performing the biopsy/intervention.

7) The second Look feature can recall a previous prostate 3D-mapping and fuse it to the live session as a plan to target unexplored area or previous positive biopsies. This is of paramount importance for the management of active surveillance patients, as well as an entry point to focal therapy planning.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Section V: Award of contract/concession

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

03/09/2020

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Koelis Advancing Prostate Care

Meylan

UK

NUTS: UKI

The contractor is an SME: No

V.2.4) Information on value of the concession and main financing terms (excluding VAT)

Total value of the concession/lot: 170 000.00 GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

High Court

The Strand

London

UK

VI.5) Date of dispatch of this notice

03/09/2020


Information added to the notice since publication.

Additional information added to the notice since it's publication.
No further information has been uploaded.
Main Contact: tenders@chelwest.nhs.uk
Admin Contact: N/a
Technical Contact: N/a
Other Contact: N/a

Commodity Categories

Commodity Categories
IDTitleParent Category
33100000Medical equipmentsMedical equipments, pharmaceuticals and personal care products

Delivery Locations

Delivery Locations
IDDescription
100UK - All

Alert Region Restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

Alert Region Restrictions
There are no alert restrictions for this notice.

Copyright © Sell2Wales